EUR 7.5m to develop software and hardware solutions to reduce food waste in professional kitchens
Food valued at EUR 900m to be saved by 2025 and 69 jobs to be supported
The European Investment Bank (EIB) has agreed to provide a EUR 7.5m loan to the Romanian food waste management company Winnow with the help of the Juncker Plan. The company will use the financing to develop and introduce software and hardware solutions to help staff in professional kitchens track the amounts and types of food wasted. The ultimate aim is to provide users with data to manage and prevent food waste.
The agreement is backed by the European Fund for Strategic Investments (EFSI), the heart of the Investment Plan for Europe, also known as the Juncker Plan. Without EFSI backing, the EIB would not be able to support this operation to the same extent – from both the debt volume and the risk perspective.
EIB Vice-President Andrew McDowell commented: “This innovative project, the first in Romania under the European Growth Finance Facility (EGFF), backed by the Investment Plan for Europe, will have a significant impact in helping to reduce food waste in commercial kitchens. It fosters research and development in Romania with the benefit of strengthening the competitiveness of the country and generating high-value jobs.”
European Commissioner for Environment, Maritime Affairs and Fisheries Karmenu Vella said: “Winnow’s objective to help professional kitchens reduce their amounts of food waste is both good for our natural resources, and it makes economic sense. By helping businesses monitor and analyse what they are throwing away each day, using innovative technology, Winnow is empowering them to change their actions. I am proud that this project is being supported by the EU bank and the Juncker Plan.”
Winnow co-founder Kevin Duffy added: “By creating job opportunities in the community, we are continuing to build a world class team in Cluj in order to deliver effectively on our roadmap ahead. We are also excited about the future of the tech community in Cluj and being one of the first AI pioneers to receive backing from the European Investment Bank is a true reflection of the hard work of our team here.”
Winnow, a company established in England in 2013, is the technology company building artificial intelligence tools to help chefs run more profitable and sustainable kitchens by cutting food waste in half. Winnow believes that food is far too valuable to waste and that technology can transform the way food is used. Winnow’s mission is therefore to help the hospitality industry tackle avoidable food waste by connecting the kitchen to empower chefs to run a more efficient operation.
About the Loan
This loan is part of the European Growth Finance Facility (EGFF), a product designed to address a (quasi-)equity gap linked to structural market failures across the EU in the provision of risk capital to late-stage venture-backed companies. European SMEs and Mid-Caps suffer from systemic shortages of large, non-dilutive financing for growth investments, both tangible and intangible. The EIB financing is expected to have a positive crowding-in effect, attracting additional private investors to companies.
The Italian Ministry of Defence has now joined the list of beneficiaries of the EU bank’s financing. This innovative EU financing operation totalling €220 million was signed between the EIB, the Ministry of Economy and Finance (MEF) and the Ministry of Defence to support the construction of three navy vessels, which will be used by the Italian Navy’s Hydrographic Institute (IIM) based in Genoa.
The EIB will provide up to €20 million to finance the research, development and innovation (RDI) strategy of PROSOL, a family business that manufactures and distributes coffee products such as instant (soluble) coffee and single-serving products (capsules). This financing comes under the European Fund for Strategic Investments, which enables the EIB Group to offer increased support for investments fostering innovation, economic growth and employment.
The EIB and Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced the signing of a €24.5 million financing agreement. The venture loan is intended to support Immunic’s ongoing phase 2 CALVID-1 trial of its lead asset, IMU-838, in patients with moderate coronavirus disease 2019 (COVID-19). In addition, it is also intended to support the potential expansion of the CALVID-1 trial into a confirmatory phase 3 trial and the commercial-scale manufacturing for IMU-838. Immunic AG, the German subsidiary of Immunic, Inc., will receive the EIB loan in three tranches upon the completion of pre-defined milestones.